Opioid Addiction as an Attachment Disorder: Part II
Behavioral Health Treatments with Newport Healthcare
November 2022
A large body of evidence supports the brain opioid theory of social attachment (BOTSA), which posits a key substrate of attachment behavior is governed by the endogenous opioid system. When viewed in the context of sociohistorical changes in the United States, the theory provides a partial explanation for the current opioid epidemic and contains important implications for treatment.
This standalone training recapitulates Part I and extends the hypothetical implications of BOTSA by addressing several common and important topics not covered in the previous training, such as:
- The role of genetics/epigenetics and trauma/early-life stress in increased vulnerability to substance use disorders.
- The benefits and risks of medication-assisted treatments (i.e., opioid agonists, partial agonists and antagonists).
- Chronic pain viewed through a disease and biopsychosocial model, along with considerations for pain management.
- Social epidemiology and the historical shift away from social factors in research and treatment of substance use disorders.
Presenter Disclaimer
Michael Roeske, PsyD, has a working relationship with Newport Healthcare. As such, he has both a financial and intellectual interest in the webinar content. The purpose of this presentation is to provide a balanced view on the cannabis and psychosis debate.
This program does not offer CE credit.
Paid for by
These topical webinars for APA members are paid for by Newport Healthcare. The content was created by Newport Healthcare and does not reflect the views of APA or its editorial staff. Email Advertising to learn more. Newport Healthcare is the national leader in behavioral health treatment for children, teens, and young adults, providing sustainable healing for mental health and co-occurring disorders.
Presenter
Michael Roeske, PsyD
Senior director, Newport Healthcare Center for Research and Innovation.
More in this series
Discusses how common factors and evidence-based methods shape psychotherapy outcomes and clinician growth
November 2025 On Demand Webinar
Mirela Loftus, MD, PhD, discusses identifying and treating depression and anxiety in adolescents and young adults
May 2025 On Demand Webinar
Michael Roeske, PsyD, examines cannabis and psychosis, covering trends, treatment, and societal disparities related to both issues
September 2024 On Demand Webinar
About one in seven young adults in the United States has a co-occurring mental illness and substance use disorder
November 2023 On Demand Webinar

